Liposomal doxorubicin combined with regional hyperthermia: Reducing systemic toxicity and improving locoregional efficacy in the treatment of solid tumors

Journal of Chemotherapy

Volumn 16, Issue SUPPL. 5, 2004, Pages 34-36

  Dvorak, Josef ^a   Zoul, Z ^a   Melichar, B ^a   Petera, J ^a   Vesely, P ^a   Vosmik, M ^a   Dolezel, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Breast cancer; Epithelial ovarian carcinoma; Hepatocellular carcinoma; Pegylated liposomal doxorubicin; Regional hyperthermia

Indexed keywords

DOXORUBICIN; LIPOSOME; MACROGOL; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; BREAST CARCINOMA; CARDIOTOXICITY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; HAND FOOT SYNDROME; HUMAN; HYPERTHERMIC THERAPY; KAPOSI SARCOMA; LIVER CELL CARCINOMA; OVARY CARCINOMA; SOLID TUMOR; TOXICITY; TREATMENT OUTCOME; TUMOR LOCALIZATION;

EID: 11144226974     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1120009x.2004.11782380     Document Type: Conference Paper

References (11)

1. Gordon AN, Fleagle JT, Guthrie D, Parkin DE, Gore ME, Lacave AJ. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. J Clin Oncol 2001; 19 (14): 3312-3322.
2. Harrington KJ, Syrigos KN, Vile RG. Liposomally targeted cytotoxic drugs for the treatment of cancer. J Pharm Pharmacol 2002; 54 (12): 1573-1600.
3. Kong G, Dewhirst MW. Hyperthermia and liposomes. Int J Hyperthermia 1999; 15 (5): 345-370.
4. Gaber MH, Wu NZ, Hong K, Huang SK, Dewhirst MW, Papahadjopoulos D. Thermosensitives liposomes: extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys 1996; 36 (5): 1177-1187.
5. Ning S, Macleod K, Abra RM, Huang AH, Hahn G. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy. Int J Rad Oncol Biol Phys 1994; 29 (4): 827-834.
6. Park JW, Stauffer P, Diederich C, et al. Hyperthermia (HT) + doxil significantly enhances drug delivery and efficacy in metastatic breast cancer of the chest wall (CW): a phase I/II study. Proc Am Soc Clin Oncol USA 2001; 20: 47a.
7. Dvorak J, Zoul Z, Melichar B, et al. Pegylated liposomal doxorubicin in combination with hyperthermia for treatment of skin metastases of breast carcinoma: a case report. Onkologie 2001; 24: 166-168.
8. Kouloulias VE, Dadoufas CE, Kouvaris JR, et al. Liposomal doxorubicin in conjunction with reirradiation and local hyperthermia treatment in recurrent breast cancer: A phase I/II trial. Clin Cancer Res 2002; 8 (2): 374-382.
9. Zoul Z, Filip S, Melichar B, Dvorak J, Odrazka K, Petera J. Weekly paclitaxel combined with local hyperthermia in the therapy of breast cancer locally recurrent after mastectomy - a pilot experience. Onkologie 2004; 27 (4): 385-388.
10. Secord AA, Jones E, Hahn CA, et al. Phase I/II trial of intravenous liposomal doxorubicin and whole abdomen hyperthermia in patients with refractory ovarian cancer. Proc Am Soc Clin Oncol USA 2004; 23:469.
11. Dvorak J, Zoul Z, Melichar B, et al. Pegylated liposomal doxorubicin in combination with hyperthermia in treatment of skin metastasis of breast carcinoma: a case report. J Clin Gastroenterol 2002; 34 (1): 96-98.